Clinical Trial Update: Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

View source ↗

Summary

A clinical trial update from Fundación EPIC evaluating an ultrathin-strut sirolimus-eluting stent with a bioabsorbable polymer in patients on chronic oral antic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Sirolimus (Sirolimus)
• Ultrathin Strut Sirolimus-eluting Stent with Bioabsorbable Polymer

Snippet

Sponsor: Fundación EPIC | Conditions: Coronary Artery Disease, Ischemic Heart Disease | Status: RECRUITING